MLYS
Mineralys Therapeutics, Inc. Common Stock ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
Mineralys Therapeutics, Inc. Common Stock (MLYS) is held by 3 tracked hedge fund(s). Largest tracked holder: ORBIMED ADVISORS LLC.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC ORBIMED ADVISORS LLC |
1.1% | 2.1M | $56M | ▲ 109% (+1.1M) | $26.08 | 2026-03-31 |
| Suvretta Capital Aaron Cowen |
1.1% | 1.5M | $42M | — | $19.80 | 2026-03-31 |
| ARMISTICE CAPITAL, LLC ARMISTICE CAPITAL, LLC |
0.6% | 1.2M | $32M | ▲ 74% (+500K) | $29.39 | 2026-03-31 |
FAQ ▾
Which hedge funds hold MLYS?
Tracked holders include: ORBIMED ADVISORS LLC, Suvretta Capital, ARMISTICE CAPITAL, LLC.
How much smart money owns MLYS?
3 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading MLYS?
No tracked Congressional trades in MLYS on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.